Expect Ingrezza to Be Saved for Patients With Severe Tardive Dyskinesia

Ingrezza (in-GREH-zah, valbenazine) is the first drug approved for tardive dyskinesia...involuntary lip smacking, facial grimaces, etc.

Tardive dyskinesia is often caused by meds that block dopamine binding...such as antipsychotics (haloperidol, risperidone, etc) and metoclopramide (Reglan, etc).

Ingrezza decreases dopamine, which helps to reduce tardive dyskinesia symptoms.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote